4/A
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001209191-16-094981
Options or other derivatives
- President and CEO acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
WILSON TROY EDWARD · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-01-29 | Grant or award : show line 1 in the form Option to purchase common stock | +125,000 | $4.80 | 2026-01-28 | 125,000 | 125,000 | D |
Loading xslF345X03/doc4a.xml…